The Uplisting Arithmetic Has Moved Twice in Eighteen Months. Here Is What an OTC Micro Cap Now Has to Clear to Reach Nasdaq.

by Imogen Farrow · September 7, 2026

Listings Reporter, The MicroCap Herald

US equity markets are closed on Monday for Labor Day, so there is no session to read. That makes it a reasonable morning to read something else instead: the rulebook that decides whether the long queue of OTC-quoted companies naming a Nasdaq uplisting as a corporate objective will ever get there. Two Securities and Exchange Commission approvals since March 2025 have moved the bar, and a third rule aimed at a specific class of applicant took effect this summer.

The first thing to understand about uplisting is that Nasdaq maintains two rulebooks, not one, and the gap between them is wide. Getting on is governed by the initial listing standards — Rule 5405 for the Nasdaq Global Market and Rule 5505 for the Nasdaq Capital Market, the tier most micro caps target. Staying on is governed by the continued listing standards in Rules 5450 and 5550. Under Rule 5550, a listed Capital Market company must maintain a minimum bid price of at least $1 per share, at least 300 public holders, at least 500,000 publicly held shares, a market value of publicly held shares of at least $1 million, and at least one of three financial standards: stockholders' equity of at least $2.5 million, market value of listed securities of at least $35 million, or net income from continuing operations of $500,000 in the most recent fiscal year or in two of the last three.

The entry test is a different document. Rule 5505(a) requires at least 1,000,000 unrestricted publicly held shares, at least 300 round lot holders — of whom at least half must each hold unrestricted securities worth $2,500 or more — and at least three registered and active market makers. The round lot holder count is a distinct kind of test, because it is a headcount of holders rather than a dollar figure a single financing can produce. Note that the rule counts round lot holders, not shareholders of record and not beneficial holders.

Then there is price. Rule 5505 sets a minimum bid price of $4 per share, with two alternatives: a minimum closing price of $3 under the equity or net income standards, or $2 under the market value of listed securities standard. Those alternatives are conditioned. Per the rulebook and Nasdaq's January 2026 Initial Listing Guide, a company using them must show net tangible assets in excess of $2 million if it has been in continuous operation for at least three years, net tangible assets in excess of $5 million if it has operated for less than three years, or average revenue of at least $6 million for the last three years. The applicable closing price must be met for at least five consecutive business days prior to approval.

This is the mechanical reason so many uplisting attempts begin with a share consolidation. A company quoted in cents on the OTC market cannot satisfy a $4 test — or even the $2 alternative — without a reverse split. It is worth stating the arithmetic plainly: a reverse split changes the share count, not the business, and Nasdaq's $1 continued listing test then applies from the new base. Clearing a price threshold by consolidation does not by itself change whether the company can hold the threshold afterwards.

The financial standards sit alongside the price test. On the Capital Market, the equity standard requires $5 million of stockholders' equity and a two-year operating history; the market value of listed securities standard requires $50 million of listed securities and $4 million of stockholders' equity; the net income standard requires $750,000 of net income from continuing operations and $4 million of stockholders' equity.

The change that matters most sits in a line item that used to vary by standard: the Market Value of Unrestricted Publicly Held Shares, or MVUPHS — the market value of the freely tradable stock actually in public hands. All three Capital Market standards now carry a $15 million MVUPHS requirement. On December 18, 2025 the Commission approved Nasdaq's filing SR-NASDAQ-2025-068, operative 30 days later, raising the MVUPHS minimum under the Capital Market net income standard from $5 million to $15 million and under the Global Market income standard from $8 million to $15 million. Nasdaq's stated concern, as recorded in the approval order, was that companies listing with just $5 million or $8 million of MVUPHS 'may not trade in a manner supportive of price discovery.'

The same order records what did not survive. Amendment No. 1 removed a proposed accelerated suspension and delisting provision. Morgan Lewis, writing when the proposals were filed on September 30, 2025, described it as applying to a company that had already become non-compliant with a numeric listing requirement and whose market value of listed securities was below $5 million for ten consecutive business days: such a company would face suspension and immediate delisting rather than the usual compliance period. What that order ultimately tightened, therefore, was entry rather than exit.

For an OTC company, the more consequential change came earlier. On March 12, 2025 the Commission approved amendments to Rules 5405 and 5505 requiring that the applicable MVUPHS requirement be satisfied solely from the proceeds of the offering. Cooley's PubCo blog and a note from McMillan describe the change and its reach the same way: it applies to initial public offerings and to OTC companies uplisting in connection with a public offering, and shares previously registered for resale, which had counted toward the float value, no longer do. Both date the new benchmarks to April 11, 2025.

That is paired with a liquidity screen most OTC issuers meet only on paper. Rule 5505(a)(5) provides that a security trading over the counter as of the date of application must have a minimum average daily trading volume of 2,000 shares over the 30 trading days before listing, with trading occurring on more than half of those days, 'unless such security is listed on the Exchange in connection with a firm commitment underwritten public offering of at least $5 million.' The Global Market's parallel provision, Rule 5405(a)(4), sets that alternative at $8 million. Cooley and McMillan both record that each figure was $4 million before the 2025 amendments.

Read together, those two provisions turn an uplisting into a financing event rather than a filing exercise. A thinly traded company that cannot demonstrate 2,000 shares a day must instead come with an underwritten deal, and that deal has to be large enough to put $15 million of unrestricted stock into public hands on its own. For an issuer whose existing public float is a fraction of that, the dilution is not incidental to the uplisting — it is the mechanism of the uplisting. Where such an offering carries attached warrants, the dilution extends past the closing date.

A separate rule now applies to one category of applicant. On May 14, 2026 the Commission approved SR-NASDAQ-2025-069, adopting Rule 5210(l), effective 30 days after approval. It covers issuers headquartered or incorporated in China, including the Hong Kong and Macau special administrative regions, or whose business is principally administered in one of those jurisdictions. Nasdaq weighs a set of factors holistically in deciding whether a business is principally administered there — where the books and records sit, whether at least half of assets, revenues, directors, officers or employees are located in or derived from the jurisdiction, and whether the company is under common control with others — but the factors identify which companies fall inside the stated scope rather than extending the rule beyond it. A covered company conducting an IPO must complete a firm commitment offering producing gross proceeds of at least $25 million to public holders. A covered company emerging from a business combination must show at least $25 million of MVUPHS. Covered companies may not list on the Global Market or Capital Market by direct listing.

The provision that bears directly on uplisting is the transfer rule. A covered company moving from the OTC market or another exchange must have traded on that market for at least one year before it is eligible to list on Nasdaq, and must show a minimum MVUPHS of at least $25 million. In its summary of the approval, Greenberg Traurig writes that from August 2022 to April 2025 about 70 percent of Nasdaq's enforcement case referrals to the SEC or FINRA relating to market manipulation involved Chinese companies, even though those companies accounted for less than 10 percent of Nasdaq listings over the period. That figure is taken from the firm's summary, not quoted here from the order itself. Nasdaq's January 2026 guide separately carries a longer-standing Restrictive Market provision requiring an IPO issuer that principally administers its business in such a market to offer securities in a US firm commitment underwritten offering producing gross proceeds of at least $25 million, or at least 25 percent of post-offering market value of listed securities, whichever is lower.

None of this makes an uplisting application readable from the outside on its own. What it does is tell a reader what a credible one has to contain. A registration statement or announcement describing an uplisting should name the standard the company intends to qualify under, state whether the bid price test is met as quoted or requires a consolidation first, and say whether the MVUPHS will be produced by the offering. Companies routinely disclose that an application has been submitted without any commitment that it will be approved, and Nasdaq retains discretion over listing decisions independent of the numeric tests. A release that announces an intention to uplist without naming a standard has told the reader very little.

The broader point is the one the two rulebooks make by themselves. Nasdaq has raised what a company must show to walk in the door twice in eighteen months, while the maintenance thresholds that are currently operative sit where they were — a $1 bid price, $1 million of publicly held share value, 300 public holders. One continued listing change is pending rather than absent: a filing, SR-NASDAQ-2026-004, would add a market value of listed securities requirement of at least $5 million to Rule 5550, and was approved under delegated authority on July 22, 2026. Petitions for review triggered an automatic stay on July 29, 2026, and the amended text is not operative while that stay stands. Readers consulting Nasdaq's online rulebook should note that it displays the stayed text under a stay notice. A company can clear a $15 million float value on its listing day and be inside a deficiency window well before its second annual report. That gap, more than any single rule change, is why the compliance notices that fill this beat arrive as reliably as they do.